Search results
Results from the WOW.Com Content Network
OCD. Dermatophagia (from Ancient Greek δέρμα — lit. skin and φαγεία lit. eating) or dermatodaxia (from δήξις, lit. biting) [ 3] is a compulsion disorder of gnawing or biting one's own skin, most commonly at the fingers. This action can either be conscious or unconscious [ 4] and it is considered to be a type of pica.
Fingernails of a nail-biter. Nail biting, also known as onychophagy or onychophagia, is an oral compulsive and unhygienic habit of biting one's fingernails. It is sometimes described as a parafunctional activity, the common use of the mouth for an activity other than speaking, eating, or drinking. Nail biting is very common, especially amongst ...
Specialty. Dermatology. Psychiatry. Excoriation disorder, more commonly known as dermatillomania, is a mental disorder on the obsessive–compulsive spectrum that is characterized by the repeated urge or impulse to pick at one's own skin, to the extent that either psychological or physical damage is caused. [ 4][ 5]
Madhvi Chittoor: TIME's Kid of the Year List. Sanya Mansoor. August 15, 2024 at 7:15 AM. Madhvi Chittoor at a river clean-up event she co-organized in Denver Credit - Courtesy Madhvi Chittoor ...
An estimated 2 million Florida children could have benefited from more than $258 million in aid this summer if state officials hadn’t turned it down. Nationwide, roughly 21 million kids are ...
Human parvovirus B19, also known as "slapped cheek disease," is on the rise in the U.S., especially among children. Here's what to know about symptoms, complications and treatment.
Body-focused repetitive behavior. Body-focused repetitive behavior ( BFRB) is an umbrella name for impulse control [ 1] behaviors involving compulsively damaging one's physical appearance or causing physical injury. [ 2] Body-focused repetitive behavior disorders ( BFRBDs) in ICD-11 is in development. [ 3]
The company has been upgrading patients who use its eye treatment, Eylea, to a higher-dose version to beat the impact from cheaper biosimilars available in the market and rival drugs. U.S. sales ...